Bilateral Laryngeal Paralysis Reinnervation - Full Text View

Bilateral Laryngeal Paralysis Reinnervation

This study is currently recruiting participants.
Verified by University Hospital, Rouen, May 2007

Sponsored by:	University Hospital, Rouen
Information provided by:	University Hospital, Rouen
ClinicalTrials.gov Identifier:	NCT00213616

Purpose

Bilateral laryngeal reinnervation induces a rise in laryngeal resistance and speech alteration. The aim of this study is to propose laryngeal reinnervation by a phrenic nerve root to patients with bilateral laryngeal paralysis.

Condition	Intervention
Vocal Cord Paralysis	Procedure: surgical reinnervation

MedlinePlus related topics:

Paralysis

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study

Official Title:	Bilateral Laryngeal Paralysis Reinnervation. Speech and Ventilatory Results Analysis

Further study details as provided by University Hospital, Rouen:

Primary Outcome Measures:

LARYNGEAL REINNERVATION

Estimated Enrollment:	10
Study Start Date:	March 2004

Eligibility

Ages Eligible for Study:	18 Years to 65 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Bilateral laryngeal paralysis without any amelioration for six months

Exclusion Criteria:

Laryngeal paralysis more than 3 years
Arycricoideus ankylostosis
Pacemaker
Pregnancy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00213616

Contacts


Contact: Jean Paul Marie, MD, PHD	33 2 32 88 82 66	jean-paul.marie@chu-rouen.fr

Locations


France
	Rouen University Hospital	Recruiting
	ROUEN, France, 76031
	Contact: Jean Paul Marie, MD, PHD 33 2 32 88 82 66 jean-paul.marie@chu-rouen.fr

Sponsors and Collaborators

University Hospital, Rouen

Investigators


Principal Investigator:	Jean Paul Marie, MD, PHD	Rouen University Hospital

More Information

Study ID Numbers:	99 - 141 HP
First Received:	September 13, 2005
Last Updated:	May 29, 2007
ClinicalTrials.gov Identifier:	NCT00213616
Health Authority:	France: Afssaps - French Health Products Safety Agency